A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD
Clinical trial NCT04571164 · COMPLETED
Trial details
- NCT number
- NCT04571164
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-11
- Primary completion
- 2022-03-17
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.